71 studies found for:    "Patent ductus arteriosus"
Show Display Options
Rank Status Study
21 Unknown  Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol;   Drug: Oral ibuprofen
22 Completed Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial
Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol;   Drug: Oral ibuprofen
23 Active, not recruiting
Has Results
AMPLATZER Duct Occluder II Clinical Study
Condition: Patent Ductus Arteriosus
Intervention: Device: AMPLATZER Duct Occluder II
24 Completed Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
Condition: Patent Ductus Arteriosus
Interventions: Drug: Continuous indomethacin;   Drug: ibuprofen
25 Completed Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
Condition: Patent Ductus Arteriosus
Intervention:
26 Withdrawn Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
Condition: Patent Ductus Arteriosus
Intervention: Device: INVOS Cerebral/Somatic oximeter
27 Completed Patent Ductus Arteriosus (PDA) Screening Trial
Condition: Ductus Arteriosus, Patent
Interventions: Other: Nondisclosure of screening echocardiogram results;   Other: Disclosure of screening echocardiogram results
28 Recruiting Paracetamol in Patent Ductus Arteriosus
Condition: Ductus Arteriosus, Patent
Interventions: Drug: Paracetamol;   Drug: Ibuprofen
29 Completed Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies
Condition: Ductus Arteriosus, Patent
Intervention:
30 Recruiting Analysis of the Impact of Patent Ductus Arteriosus on Brain Function in Preterm Neonates: Multimodal Approach Integrating EEG-NIRS, Ultrasound and Clinical Data
Condition: Ductus Arteriosus, Patent
Interventions: Device: TFU-NIRS;   Device: NIRS;   Device: EEG
31 Withdrawn Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Drug: Ibuprofen
32 Recruiting PDA Post NICU Discharge
Condition: Patent Ductus Arteriosus
Intervention:
33 Recruiting The Best Treatment Strategy: Surgical vs Pharmacological to Close the Ductus Arteriosus Persistent in Preterm Infants
Condition: Persistent Ductus Arteriosus
Interventions: Procedure: Surgical treatment;   Drug: Control group
34 Completed
Has Results
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
Condition: Patent Ductus Arteriosus
Intervention: Device: PES first, then FFES
35 Active, not recruiting Paracetamol Treatment of the Borderline Significant PDA
Condition: Patent Ductus Arteriosus
Interventions: Drug: Paracetamol drops;   Other: Placebo
36 Terminated Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
Condition: Patent Ductus Arteriosus
Interventions: Drug: optimized ibuprofen;   Drug: Standard Ibuprofen
37 Completed Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA
Condition: Patent Ductus Arteriosus
Intervention: Drug: ibuprofen l-lysine iv solution (NeoProfen (R) )
38 Completed Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Other: feeding;   Other: fasting
39 Recruiting Chest Shielding in Premature Infants During Phototherapy
Condition: Patent Ductus Arteriosus in Premature Infants
Interventions: Device: Chest shield with aluminum foil (CALF);   Device: SHIELD
40 Not yet recruiting Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.
Conditions: Ductus Arteriosus Patent;   Respiratory Distress Syndrome
Interventions: Drug: Intravenous paracetamol;   Drug: Intravenous ibuprofen

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years